NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/06/2026 14:35
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization920.25 mln
Float64.40 mln
Earnings Date04/30/2026
Piotroski F-Score
3
/ 9
Below average
1-Year Forecast
29.67
Transformational upside
Relative Strength
2
/ 100
Severely lagging
Debt / Equity
-3.17
Negative equity
ROE
-425
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Adlai Nortye Ltd. is a Cayman Islands-based company founded in 2004 that focuses on developing new cancer treatments across the United States and other markets. The company has several drugs in early-stage clinical trials, targeting a range of cancers including pancreatic, lung, colorectal, esophageal, and rectal cancer. Its pipeline includes treatments that work by helping the immune system recognize and attack tumors, as well as drugs that block specific proteins known to drive cancer growth.
